In this episode, the lead investigator moves forward with controlled testing of her newly formulated compounds on willing participants from the nursing team. Detailed monitoring captures the varied responses as each subject receives either the blue or red variant, with careful notes on physical and behavioral shifts. She also administers a dose to herself, recording her own reactions alongside the others. The session yields preliminary data that hints at promising yet unpredictable results ahead.
